Jon Napitupulu

Nutcracker Therapeutics, a biotechnology company specializing in RNA therapies, announced its participation in the 2024 Personalized Cancer Vaccine Summit,...

Lantern Pharma, through its subsidiary Starlight Therapeutics, revealed preclinical data and Phase 1b trial designs for LP-184 (STAR-001 for...

Exelixis announced that the FDA will discuss its supplemental New Drug Application for cabozantinib, intended to treat advanced pancreatic...

Virpax Pharmaceuticals has announced an extension of its research agreement with the National Center for Advancing Translational Sciences (NCATS),...

Everest Group has positioned eClinical Solutions as a Leader in Life Sciences Clinical Data and Analytics Platforms in their...

Narsoplimab, a first-in-class antibody targeting MASP-2, the effector enzyme of the complement lectin pathway, is under development for hematopoietic...

A recent multicenter, prospective randomized controlled clinical trial evaluated a new adaptive nomogram within the Aurora Xi Plasmapheresis System...

A groundbreaking study published in The Lancet Neurology demonstrates the ability of a novel synuclein seed amplification assay (synSAA)...

NorthStar Medical Radioisotopes and Cellectar Biosciences forged a strategic partnership which centers around the supply of non-carrier-added (n.c.a.) Actinium-225...

Laekna, a global biotechnology company specializing in metabolic and cancer drug development, has partnered with Eli Lilly and Company...